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INTRODUCTION 
Cancer is considered as one of the most 
common causes of death worldwide because 
it's incidence and prevalence is increasing.
1-4
 
It is estimated that cancer prevalence 
increases up to 45% in developing countries 
by 2025.
5-9
 Cancers are important in 
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ABSTRACT 
Background and aims: Stomach cancer is one of the most common cancers and the 
second cause of deaths among cancers worldwide cancer in the world. This study aimed 
to estimate the rate and trend of death from stomach cancer in Iranian population between 
2006 and 2010. 
Methods: This study was a cross-sectional conducted using mortality data in Iranian 
population between 2006 and 2010. The number of deaths, death rate, and sex ratio of 
mortality, mortality rates by age and gender groups, and trends of mortality from stomach 
cancer were calculated and reported. Cochrane Armitage test was used for linear trend by 
Winpepi software to study the trends of Stomach cancer mortality. 
Results: The results showed that between 2006 and 2010, 34950 cases of death have 
been reported from stomach cancer. The mortality rate per 100,000 reached from 11.22 in 
2006 to 11.06 in 2010. All years studied indicated that death due to stomach cancer were 
higher in males than females. Also, with increasing age, the mortality rate of stomach 
cancer was increased. 
Conclusion: Our findings showed the decreasing trend of mortality due to stomach 
cancer may be due to increasing in lifespan and survival, enjoying the better diagnostic 
and therapeutic procedures for patients, and underestimation of the number of stomach 
cancer deaths. Since the cancer is the most frequent cause of death among cancers in Iran, 
additional investigation is necessary to determine the risk factors of the cancer to decline 
the mortality rate. 
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designing and planning health system 
programs due to irreparable consequences 
and staggering costs of diagnosis and 
treatment. More than half of the cancers and 
60% of cancer deaths occur in less 
developed countries, and along with 
changing lifestyle, similar to the Western 
countries, cancer incidence is increasing in 
developing countries.
10
 
Among the cancers, gastrointestinal 
cancer is prevalent in Iranian men while 
breast cancer is the most common cancer in 
Iranian women. Based on cancer registry 
reports in Iran stomach cancer is the most 
frequent, then the colon and rectum cancers 
are the most common gastrointestinal 
cancers.
10
 Latest reports indicated that the 
incidence of stomach cancer is nearly 
934,000 cases per year, and the cancer is 
considered the fourth most common cancer 
and after lung cancer, the second cause of 
deaths from cancer in the world.
5
 In 
contrast with the declining trend of stomach 
cancer worldwide, new cases of the cancer 
are increasing every year.
11
 It also has 
remained as a public health problem in 21 
countries. This could be due to increasing 
in the human lifespan.
12
 
Stomach cancer is one of the most 
important gastrointestinal tract cancers.
13
 
According to the estimations of the 
International Agency for Research on 
Cancer (IARC) in 2012; stomach cancer is 
the fourth most common cancer in the 
world. Half of the cases occur yearly in 
East Asia and mostly in China. Stomach 
cancer is third cancer mortality of both 
sexes in the worldwide. Moreover, in 2012 
in Iran Stomach cancer accounted for 
11.4% of all cases of cancer occurrence 
and was considered as the second most 
prevalent cancer. In the same year, 
Stomach cancer which accounted for 15.5 
percent of all mortalities caused by 
cancers was in fact the most deadly cancer 
in Iran.
14-17
 The current global trend of 
stomach cancer incidence has shown a 
substantial decline since 1975, when 
stomach cancer was the world’s most 
common cancer.
18
 Stomach cancer is much 
more common in certain Asian, Central 
European, Central American, and South 
American countries, especially Japan, 
Chile, Costa Rica, Hungary, and Poland. 
The highest incidence of stomach cancer 
occurs in Japan and Eastern Asia; by 
contrast, its incidence is relatively low in 
Western Europe.
19
 
Smoking and chronic infections are the 
most important risk factors for all cancers, 
especially stomach cancer so that they cause 
30% and 10% of all cancers, respectively.
1 
Some studies expressed that Helicobacter 
pylori and poor diet are the most important 
determinant factor for stomach cancer. 
Helicobacter pylorus, as one of the most 
common human infections worldwide, has 
prevalence of 50% in the world and 90% in 
developing countries. The prevalence of 
bacterium is also high in Iran.
20
 High-salt 
diet is another risk factor but a healthy diet, 
including fresh fruits and vegetables, may 
reduce the risk of disease.
21
 
One of the most important steps in 
controlling cancer is collecting data on 
cancer mortality in any country. To evaluate 
activities for cancer control, monitoring 
trends in cancer mortality by demographic 
characteristics and time is necessary. This 
study aimed to estimate the rate and trend of 
death from stomach cancer in Iranian 
population between 2006 and 2010. 
 
METHODS 
The present study was a cross-sectional 
using data on mortality in Iran during 2006-
10. Data were collected by Technology and 
Applied Research and Information 
Management Center of the Ministry of 
Health and Medical Education from various 
sources including National Organization for 
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Civil Registration, cemeteries, hospitals, and 
care homes. The necessary data integration 
has been performed in the Ministry of 
Health and Medical Education.
22
 
In the present study, the data on the 
number of deaths from Stomach cancer 
during 2006-10 in 29 provinces of Iran were 
obtained based on mortality in Iran after 
removing empty codes, and were entered on 
a pre-designed form. Meanwhile, cancers 
were coded based on The International 
Classification of Diseases for Oncology 
ICD-O (second edition). The C16 code was 
given to Stomach cancer. Number of deaths, 
mortality rate, male/female mortality ratio, 
and mortality rates in the age and sex groups 
were calculated and reported. Moreover, a 
picture of the trend of changes in mortality 
due to Stomach cancer in Iran was drawn. 
Charts with excel 2010 software was 
performed. 
Cochrane Armitage test was used for 
linear trend by Winpepi software 2.1 to 
study the trends in cancer mortality. 
 
RESULTS 
In this study, all data on mortality from 
stomach cancer was investigated in all sex 
and age groups between 2006 and 2010. Of 
34, 950 deaths from stomach cancer 
reported, 22,695 cases occurred in men and 
12,255 in women. The highest number of 
deaths in males (6105 cases) and females 
(4050 cases) was seen in 2010. Overall, the 
number of deaths was more in men than 
women and the sex ratio was 1.85. 
The results obtained from calculation of 
mortality rates per 100,000 people showed 
that the death rates from stomach cancer 
reached from 11.22 in 2006 to 11.06 in 
2010. Mortality rates in all years studied 
indicated stomach cancer prevalence was 
higher in males than females. As shown in 
Table1and Figure1, the mortality rate in 
males reached from 14.7 per 100,000 people 
in 2006 to 14.51 per 100,000 people in 
2010, while the rate was 7.64 per 100,000 
people in 2006 and 7.53 per 100,000 people 
in 2010 among females. 
 
Table 1: Mortality from stomach cancer per hundred thousand people in the study group sex 
Sex ratio Crude mortality rate Mortality per hundred thousand Year of study 
Total Men Woman Total Men Woman 
1.98 6407 4260 2147 11.20 14.70 7.64 2006 
2.00 6234 4159 2075 11.75 15.47 7.92 2007 
2.08 6074 4103 1971 11.31 15.09 7.43 2008 
2.02 6080 4068 2012 11.17 14.78 7.49 2009 
1.50 10155 6105 4050 11.06 15.51 7.53 2010 
1.85 34950 22695 12255    Total 
 
 
Figure 1: The rate of death from stomach cancer per hundred thousand people in the study group sex 
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As seen in Table 2 and Figure 2, results in 
all sex and age groups studied showed with 
increase in age, the mortality rate of stomach 
cancer also increases. The lowest mortality 
rate due to the cancer was observed in the age 
group of less than 5 years and between 5 to  
14 years, but as age increases, the rate 
increased in people over 70 years. In other 
words, in men older than 70 years, the 
mortality rate was increased from 244.85 per 
100,000 people in 2006 to 243.44 per 100,000 
people in 2010, and in women, the rate was 
118.71 per 100,000 in 2006 and 123.84 per 
100,000 in 2010. 
 
Table 2: The rate of death from stomach cancer per hundred thousand in the year under study, by 
sex and age group 
Above 70 years 50-69 15-49 5-14 Under 5 years Year of 
Study T M W T M W T M W T M W T M W 
175.44 224.85 118.71 37.68 48.94 26.62 1.95 2.41 1.47 0 0 0 0 0 0 2006 
189.22 241.78 129.49 37.30 49.81 25.14 2.23 2.79 1.66 0 0 0 0 0 0 2007 
186.32 246.58 118.92 36.79 49.22 24.74 1.76 2.10 1.43 0 0 0 0 0 0 2008 
188.30 242.14 129.07 35.28 47.81 23.15 1.70 2.19 1.20 0 0 0 0 0 0 2009 
185.98 243.44 123.84 33.77 44.49 23.38 1.92 2.38 1.45 0 0 0 0 0 0 2010 
 
 
Figure 2: The rate of death from stomach cancer per hundred thousand in the year under study, 
by sex and age 
 
DISCUSSION 
Studies determined that stomach cancer is 
the most frequent cause of death among cancer 
from tumor mass in the world and the most 
frequent cause of death from cancer in Iran. The 
mortality rate from the cancer was 8.4 
per100,000 in East Azerbaijan and north of Iran 
compared with 3.6 per 100,000 in south of 
Iran.
23,24
 In comparison during the last decades, 
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the mortality due to the cancer has significantly 
decreased in most developed countries, in some 
Asian countries(China, Korea and Japan), East 
Europe, and South America there is a high 
prevalence.
25
 According to the estimations of the 
International Agency for Research on Cancer 
(IARC) in 2012, stomach cancer is the fourth 
most common cancer in the world. Half of the 
cases occur yearly in East Asia and mostly in 
China. Stomach cancer is third cancer mortality 
of both sexes worldwide. Moreover, in 2012 in 
Iran Stomach cancer accounted for 11.4% of all 
cases of cancer occurrence and was considered 
as the second most prevalent cancer. In the same 
year, stomach cancer which accounted for 15.5 
percent of all mortalities caused by cancers was 
in fact the most deadly cancer in Iran.
16,17,26
 In 
Iran, while the northern and northwestern 
regions are high risk areas for gastric cancer, 
there are several intermediate and low risk 
populations in other geographical areas.
2
 
Stomach cancer is the second common cancer in 
Iranian men and the forth in Iranian women. Its 
incidence is more in males than females.
27
 In 
Iran, most northern and north western areas are 
at high risk for stomach cancer, whereas the 
central and western provinces are at medium risk 
and the southern regions are at a low risk.
15
 The 
highest incidence of Stomach cancer in the 
country was seen in Mazandaran, Golestan, and 
Ardabil provinces but the lowest was reported 
from the Kerman province.
28
 Another study 
showed that the greatest rate was reported from 
the Ardebil province and the lowest was 
observed in Khuzestan and Chaharmahal and 
Bakhtiari provinces.
29 
Findings indicated that the mortality rate 
due to stomach cancer has been constant during 
years of the study. That is, the mortality rate 
reached from11.22to11.06. Another study 
revealed that stomach cancer mortality rate has 
increased from 1.64to9.67 per 100,000 between 
1995 and 2003.
30
 A study reported that in 2004 
deaths from the cancer were 12.02 per100,000.
31
 
It is also shown that the mortality rate was 15 
and 8.1 per 100,000 in men and women, 
respectively.
32 
In our study, deaths from the cancer were 
more in patients over 70 years. In other words, 
as age increases, the mortality rate increases. A 
study conducted in the Mazandaran province, 
North of Iran, also emphasized that the mortality 
rate was more in people over60 than other age 
groups. As well, the mean age at death was 
higher for men than women.
33 
Our results; 
similar to some studies showed that sex ratio 
(male/female) for stomach cancer mortality was 
1.85, unlike some studies that reported the sex 
ratio of males to females as doubled.
32-35
 
Etiologic factors related to stomach cancer 
are unknown but many environmental factors, 
such as age, sex, blood group, heredity, poor 
diet, geographical area, smoking, and alcohol, 
are possible risk factors for developing the 
cancer.
35,36
 Given the significant geographic and 
ethnic differences in the incidence of stomach 
cancer in various areas, it can be concluded that 
the cancer risk is specified to a large extent by 
environmental factors such as dietary factors and 
Helicobacter pylori infection.
28
 Helicobacter 
pylori is considered as the most infectious agent 
for developing stomach cancer.
37,38
 The 
prevalence of this infection is high in Iran.
39
 The 
prevalence of Helicobacter pylori in the 
developing countries, including Iran, is more 
than 80% and in developed countries less than 
30%.
38
 In a population-based study, conducted 
in Ardebil (a province in West of Iran), 90% of 
the population at risk of the infection was known 
and the lowest prevalence of the bacterium was 
seen in the Sistan and Baluchistan province, 
south East of Iran, where there is the lowest 
incidence of stomach cancer.
40,41
 
The results obtained from this study is 
different from other studies regarding mortality 
from stomach cancer because the findings 
showed that  the  mortality rate of the cancer is 
decreasing, while another study on the data of 
cancer registry reported an increasing trend 
related to deaths from the disease.
2,42-44
 
However, the decrease may be due to increasing 
lifespan and survival, enjoying the better 
diagnostic and therapeutic procedures for 
patients and underestimation of the number of 
death due to stomach cancer. Since the cancer 
has the most frequent deaths from cancers in 
Iran, additional investigation is necessary to 
determine risk factors of the cancer to reduce the 
mortality rate. Diagnostic interventions are 
required to reduce death from this cancer. 
Data on cancer mortality can be used to 
guide policy makers in order to setup cancer 
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prevention programs. But this aim needs reliable 
death registry systems which reports death 
statistics annually. On the other hand, the 
analysis of death statistic subject to 
misclassification is a major problem in 
epidemiological analysis leading to biases 
estimates, and can therefore cause one to 
underestimate health risks.
45
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